Boosting Protection: Mail Screening | American Bankers Association

The recent targeting of United Healthcare's CEO highlights the significant impact the loss of key executives can have on a company's value and brand. In recent years, "white powder" attacks delivered through the mail have become increasingly common. BioFlyte offers advanced mail screening technology to detect chemical and biological threats, enhancing executive protection. Our technology identifies critical threats such as anthrax, ricin, and fentanyl, even in trace amounts, ensuring early detection before distribution. By operating in a safe, controlled environment, we minimize the risk of contamination within facilities.

• Mark Russo, Head of Markets, BioFlyte
• Paul Benda, EVP, Risk, Fraud & Cybersecurity, ABA